Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review

September 2021 | 53 pages | ID: A0C7D9ED76E8EN
GlobalData

Abstracts

Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate, tabelecleucel in Phase III clinical trials for the treatment of epstein-barr virus associated post-transplant lymphoproliferative disorder (EBV+ PTLD) following hematopoietic cell transplant and solid organ transplant in patients who refracted rituximab. Its pipeline product candidates that are being developed for multiple indications in various stages of clinical trials include ATA188, ATA2271, ATA3219, ATA3271 and other CAR T programs. Atara is headquartered in San Francisco, California, the US.

Atara Biotherapeutics Inc Key Recent Developments

Aug 09,2021: Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors
Aug 09,2021: Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress
Aug 02,2021: Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
May 10,2021: Atara Biotherapeutics Names Cell Therapy & Oncology Leader Cokey Nguyen, Ph.D. as Chief Scientific Officer
May 04,2021: Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Atara Biotherapeutics Inc - Key Facts
Atara Biotherapeutics Inc - Key Employees
Atara Biotherapeutics Inc - Key Employee Biographies
Atara Biotherapeutics Inc - Major Products and Services
Atara Biotherapeutics Inc - History
Atara Biotherapeutics Inc - Company Statement
Atara Biotherapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Atara Biotherapeutics Inc - Business Description
R&D Overview
Atara Biotherapeutics Inc - Corporate Strategy
Atara Biotherapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Atara Biotherapeutics Inc - Strengths
Atara Biotherapeutics Inc - Weaknesses
Atara Biotherapeutics Inc - Opportunities
Atara Biotherapeutics Inc - Threats
Atara Biotherapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Atara Biotherapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 09, 2021: Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors
Aug 09, 2021: Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress
Aug 02, 2021: Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
May 10, 2021: Atara Biotherapeutics Names Cell Therapy & Oncology Leader Cokey Nguyen, Ph.D. as Chief Scientific Officer
May 04, 2021: Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress
Mar 09, 2021: Atara Biotherapeutics to Participate in Virtual 33rd Annual ROTH Conference
Mar 01, 2021: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
Feb 18, 2021: Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
Feb 08, 2021: Atara Biotherapeutics presents key data for advancing the development of Tab-cel and ATA188 at the 2021 Transplantation & Cellular Therapy Meeting digital experience
Jan 10, 2021: Atara Biotherapeutics will present recent advancements and key upcoming milestones at the 39th Annual J.P. Morgan Healthcare conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Atara Biotherapeutics Inc, Key Facts
Atara Biotherapeutics Inc, Key Employees
Atara Biotherapeutics Inc, Key Employee Biographies
Atara Biotherapeutics Inc, Major Products and Services
Atara Biotherapeutics Inc, History
Atara Biotherapeutics Inc, Other Locations
Atara Biotherapeutics Inc, Subsidiaries
Atara Biotherapeutics Inc, Key Competitors
Atara Biotherapeutics Inc, Ratios based on current share price
Atara Biotherapeutics Inc, Annual Ratios
Atara Biotherapeutics Inc, Annual Ratios (Cont...1)
Atara Biotherapeutics Inc, Interim Ratios
Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Atara Biotherapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Atara Biotherapeutics Inc, Performance Chart (2016 - 2020)
Atara Biotherapeutics Inc, Ratio Charts
Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Atara Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021